We found a match
Your institution may have rights to this item. Sign in to continue.
- Title
Reduced-Intensity Chemotherapy Plus Inotuzumab Ozogamicin, With or Without Sequential Blinatumomab, is Highly Effective as First Salvage Treatment in Patients with Relapsed/Refractory B-Cell Acute Lymphoblastic Leukemia.
- Authors
Short, Nicholas; Jabbour, Elias; Sasaki, Koji; Ravandi, Farhad; Huang, Xuelin; Kebriaei, Partow; Jain, Nitin; Garcia-Manero, Guillermo; Kadia, Tapan; Konopleva, Marina; Jacob, Jovitta; Garris, Rebecca; Cortes, Jorge; O'Brien, Susan; Kantarjian, Hagop
- Publication
Clinical Lymphoma, Myeloma & Leukemia, 2019, Vol 19, pS186
- ISSN
2152-2650
- Publication type
Article
- DOI
10.1016/j.clml.2019.07.026